Explanation
Fuuoxetine
TherearenumerousvariationsinthecytochromeP450isoenzvmesvstem eadinqtodifferences in how
patientsrespondtocertain druas.Patientswhoaresuow metabouisers wiL have increasedconcentrations of
adverseeffects;rapid metabolisersmay havelower druc
nigherrate
drugsandhave
occurrence
concentrations and ess therapeuticresponse.DrugsthataremetabolisedviaCYP-2D6 includetricyclic
antidepressants.beta-blockers(especially metoprolou.dihydrocodeine.ecstasv (MDMA) andcertain seective
serotoninreuptakeinhibitors.DihvdrocodeineismetabouisedbvcvtochromeCY2D6tomorohine.theactive
analqesic.PatientswhoareCY2D6poormetabolisers wilhaveless analaesic responsetodihyvdrocodeine.
OtherP450isoenzvmesareCY2C8(omeprazole.diazepam. barbiturates) and CY2C18/19(omeprazole
diazepam.tricyclicantidepressants.proguaniU.
@1MINENDOCRINE
